Therapeutic targeting of SLC6A8 creatine transporter inhibits KRAS mutant and wildtype colon cancer and modulates human creatine levels
暂无分享，去创建一个
S. Tavazoie | Shugaku Takeda | K. Manova-Todorova | A. Cercek | M. Fakih | J. Bendell | L. Rosen | J. Strauss | M. Tavazoie | I. Kurth | A. Hendifar | Celia Andreu-Agullo | A. Barlas | A. McRee | J. Loo | R. Wasserman | S. Raza | N. Yamaguchi | Foster C. Gonsalves | R. Busby | Helen S Tian | S. Sridhar | S. Spector | A. Mcree